Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Other divalent and trivalent metal ions refers to a broad category of inorganic cations, including essential trace elements and toxic heavy metals, that serve as therapeutic targets primarily in cases of toxicity or metabolic imbalance (StatPearls, 'Chelation Therapy', 2023). This group encompasses divalent ions such as lead (Pb2+), mercury (Hg2+), and copper (Cu2+), as well as trivalent ions like iron (Fe3+) and aluminum (Al3+) (NIH, 'Metal Toxicity', 2022). Biologically, these ions often function as critical enzyme cofactors or structural elements in proteins, but their accumulation can lead to oxidative stress and organ damage (PubMed, PMC6412743). Pharmacological intervention typically involves chelating agents like EDTA, deferoxamine, or penicillamine, which sequester these ions into stable complexes for renal or fecal excretion (PubChem, 'Chelating Agents'). While essential for treating conditions like Wilson's disease or lead poisoning, targeting these ions carries risks, including the depletion of necessary minerals and potential nephrotoxicity (Mayo Clinic, 'Chelation Therapy'). Additionally, certain trivalent ions like gadolinium are used as contrast agents, though they require careful management to avoid systemic deposition (FDA, 'Gadolinium-based Contrast Agents').
Chelation therapy involves the administration of ligands that bind to divalent or trivalent metal ions to form stable, ring-like coordination complexes. These complexes are typically water-soluble and chemically inert, preventing the metal ions from interacting with biological molecules and facilitating their excretion through the kidneys or bile (StatPearls, 2023).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Other divalent and trivalent metal ions.